Clinical Trial

Cross-sectional Study of Vitamin B6 in Parkinson's Disease

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to estimate the prevalence of abnormal serum levels of vitamin B6, and the associations of those levels with demographic and clinical variables in a randomly selected sample of people living with Parkinson's disease, compared to historical controls.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-17.
Trial Details
NCT Number NCT07430722
Lead Sponsor University of Rochester
Conditions Parkinson's Disease (PD)
Enrollment 288 participants
Start Date 2024-07-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-02-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-27